SCHEMBL25753540

SCHEMBL25753540

COC(=O)C[C@H](N[S+]([O-])C(C)(C)C)c1cc(Cl)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC13A3 Q8WWT9 1/20 0.35
GPR35 Q9HC97 2/20 0.33
CTSA P10619 2/20 0.33
DDR1 Q08345 5/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
KLRK1 P26718 1/20 0.32
MICA Q29983 1/20 0.32
RAET1L Q5VY80 1/20 0.32
RAPGEF3 O95398 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.31
CETP P11597 2/20 0.31
MAPK1 P28482 1/20 0.31
LMNA P02545 1/20 0.31
WDR5 P61964 1/20 0.31
GRN P28799 1/20 0.31
SORT1 Q99523 1/20 0.31
EEF2K O00418 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30388831 1.00 SLC13A3 (0.35) SLC13A3GPR35CTSADDR1KDM4E
SCHEMBL25752815 1.00 SLC13A3 (0.35) SLC13A3GPR35CTSADDR1KDM4E
SCHEMBL24036736 0.92 TACR1 (0.34) GPR35CTSAMAPTCETPEEF2K
SCHEMBL25753566 0.92 TACR1 (0.34) GPR35CTSAMAPTCETPEEF2K
SCHEMBL25622767 0.92 TACR1 (0.34) GPR35CTSAMAPTCETPEEF2K
SCHEMBL25622879 0.90 L3MBTL1 (0.37) MAPTMAPK1LMNAWDR5GRN
SCHEMBL25753602 0.90 L3MBTL1 (0.37) MAPTMAPK1LMNAWDR5GRN
SCHEMBL24036777 0.90 L3MBTL1 (0.37) MAPTMAPK1LMNAWDR5GRN
SCHEMBL28926694 0.89 EEF2K (0.40) SLC13A3CTSADDR1KLRK1MICA
SCHEMBL24036735 0.88 CETP (0.32) CETPEEF2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 SLC13A3 286/4885GPR35 2093/4885CTSA 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.